Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2026-03-11 @ 2:53 PM
Study NCT ID:
NCT02638220
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2015-11-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Sponsor:
Travere Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09
Start Date Type:
None
Primary Completion Date:
2021-02-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-19
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-23
First Submit QC Date:
None
Study First Post Date:
2015-12-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-06-08
Results First Submit QC Date:
None
Results First Post Date:
2024-09-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-30
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL